JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lane, D. A.
Right arrow Articles by Preissner, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lane, D. A.
Right arrow Articles by Preissner, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 262, Issue 34, 16343-16348, 12, 1987

Structural requirements for the neutralization of heparin-like saccharides by complement S protein/vitronectin

DA Lane, AM Flynn, G Pejler, U Lindahl, J Choay and K Preissner
Department of Haematology, Charing Cross and Westminister Medical School, London, United Kingdom.

S protein, a major inhibitor of the assembly of the membrane attack complex of complement, has recently been shown to be identical to the serum spreading factor vitronectin. It also neutralizes the anticoagulant activities of heparin. We have studied the structural requirements for the heparin neutralizing properties of S protein/vitronectin using heparin, heparan sulfate, and heparin oligosaccharides with well defined anticoagulant specificities. The abilities of heparin fractions, Mr 7,800-18,800, with high affinity for antithrombin, and of the International Heparin Standard, to accelerate the inactivation of thrombin and Factor Xa by antithrombin were readily neutralized by S protein/vitronectin. Binding and neutralization of heparin by S protein/vitronectin was inhibited by heparin with low affinity for antithrombin, indicating that S protein/vitronectin can interact with a region on the heparin chain that might serve as a proteinase binding site. S protein/vitronectin efficiently neutralized oligosaccharides of Mr 2,400-7,200, unlike the two other physiologically occurring heparin neutralizing proteins histidine-rich glycoprotein and platelet factor 4. Furthermore, S protein/vitronectin neutralized the anti-Factor Xa activity of a synthetic pentasaccharide comprising the antithrombin-binding sequence of heparin. High molar excess of a synthetic tridecapeptide corresponding to part (amino acids 374-359) of the proposed glycosaminoglycan binding domain of S protein/vitronectin neutralized high affinity heparin and some oligosaccharides, but failed to neutralize the synthetic antithrombin- binding pentasaccharide. Like platelet factor 4, but unlike histidine- rich glycoprotein, S protein/vitronectin readily neutralized the anticoagulant activities of heparan sulfate of Mr approximately 20,000. These findings suggest that S protein/vitronectin may interact through its glycosaminoglycan binding domain(s) with various functional domains of the heparin (heparan sulfate) molecule, including the antithrombin- binding pentasaccharide sequence. Furthermore, the results suggest that S protein/vitronectin may be a physiologically important modulator of the anticoagulant activity of heparin-like material on or near the vascular endothelium.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. D. Gibson, J. A. Lamerdin, P. Zhuang, K. Baburaj, E. H. Serpersu, and C. B. Peterson
Orientation of Heparin-binding Sites in Native Vitronectin. ANALYSES OF LIGAND BINDING TO THE PRIMARY GLYCOSAMINOGLYCAN-BINDING SITE INDICATE THAT PUTATIVE SECONDARY SITES ARE NOT FUNCTIONAL
J. Biol. Chem., March 5, 1999; 274(10): 6432 - 6442.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Seiffert and J. W. Smith
The Cell Adhesion Domain in Plasma Vitronectin Is Cryptic
J. Biol. Chem., May 23, 1997; 272(21): 13705 - 13710.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Veiga, M. C. Q. B. Elias, W. Gremski, M. A. Porcionatto, R. da Silva, H. B. Nader, and R. R. Brentani
Post-translational Modifications of alpha 5beta 1 Integrin by Glycosaminoglycan Chains. THE alpha 5beta 1 INTEGRIN IS A FACULTATIVE PROTEOGLYCAN
J. Biol. Chem., May 9, 1997; 272(19): 12529 - 12535.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Seiffert and D. Seiffert
The Glycosaminoglycan Binding Site Governs Ligand Binding to the Somatomedin B Domain of Vitronectin
J. Biol. Chem., April 11, 1997; 272(15): 9971 - 9978.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Zhuang, A. I. Chen, and C. B. Peterson
Native and Multimeric Vitronectin Exhibit Similar Affinity for Heparin. DIFFERENCES IN HEPARIN BINDING PROPERTIES INDUCED UPON DENATURATION ARE DUE TO SELF-ASSOCIATION INTO A MULTIVALENT FORM
J. Biol. Chem., March 14, 1997; 272(11): 6858 - 6867.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B.-L. Lim, K. B.M. Reid, B. Ghebrehiwet, E. I.B. Peerschke, L. A.E. Leigh, and K. T. Preissner
The Binding Protein for Globular Heads of Complement C1q, gC1qR. FUNCTIONAL EXPRESSION AND CHARACTERIZATION AS A NOVEL VITRONECTIN BINDING FACTOR
J. Biol. Chem., October 25, 1996; 271(43): 26739 - 26744.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1987 by the American Society for Biochemistry and Molecular Biology.